Weighing the Evidence for PCI Decision-Making in Patients with Stable CAD.
Circulation. 2012 Mar 22;
Authors: Boden WE
Since the first percutaneous coronary intervention (PCI) was performed 35 years ago, there have been profound and sustained evolutions in catheter-based revascularization that has shifted the treatment of patients with coronary artery disease (CAD) largely away from an initial pharmacologic approach to one that has increasingly emphasized an anatomically-driven management strategy. Because there are abundant clinical trials data that support the benefit of urgent/emergent PCI in patients with ST-segment elevation myocardial infarction or non-ST-segment elevation acute coronary syndromes (ACS) in reducing death or myocardial infarction (MI),(1-6) there has been an expanding use of PCI and physician embracement of coronary stenting that has revolutionized patient management and clinical outcomes in these high-risk patients. (SELECT FULL TEXT TO CONTINUE).
PMID: 22441936 [PubMed - as supplied by publisher]